GSK Montrose uses unique technology from Dec to respond to huge production requirement for anti-flu drug. GSK Montrose is a 45 acre site located on the coast in Angus, Scotland. The site performs primary manufacture of active pharmaceutical ingredients and specialises in respiratory, steroid and anti viral products that are shipped to customers worldwide. In the summer of 2009, GSK had an immediate and urgent requirement to rapidly increase its production of the anti-flu drug Relenza in response to a potential global health crisis, a flu pandemic. In order to facilitate this requirement, the refurbishment and upgrade of an existing installation was agreed for the GSK Montrose plant. The Dec Group's technology, the Powder Transfer System (PTS), was already well established on the site and used in many production areas for the safe charging of potent powders to reaction vessels. So it came as no surprise that the PTS Would be used on this project. There was also now however a specific and urgent challenge for GSK Montrose to rapidly increase the production of Relenza, namely to charge up to twenty 10kg bags in less than twenty minutes whilst protecting the operator. So something new was required.
展开▼
机译：GSK Montrose从12月开始使用独特的技术来应对抗流感药物的巨大生产需求。 GSK Montrose是一个占地45英亩的场地，位于苏格兰安格斯（Angus）海岸。该站点主要从事活性药物成分的生产，专门研究呼吸，类固醇和抗病毒产品，这些产品已运往世界各地的客户。 2009年夏天，为了应对潜在的全球性健康危机（流感大流行），葛兰素史克迫切需要迅速增加其抗流感药物Relenza的产量。为了满足这一要求，已同意对GSK Montrose工厂进行现有设备的翻新和升级。 Dec Group的技术，即粉末转移系统（PTS），已在现场建立了良好的基础，并已在许多生产区域用于将强力粉末安全地装入反应容器中。因此，将PTS用于该项目也就不足为奇了。然而，现在，GSK Montrose面临着一个特殊而紧迫的挑战，即要快速提高Relenza的产量，即在不到二十分钟的时间内为多达20个10公斤的袋子装料，同时保护操作员。因此，需要一些新的东西。
展开▼
